Loan-Bundling Ban, Hospitals as Distributors, Garages as Sellers: How IRDAI's Distribution Paper Redraws Embedded Insurance

IRDAI's distribution consultation paper of 23 September 2026 has mostly been discussed as a commission story: caps, disclosure and what brokers and agents will earn. That framing misses the part of the paper that will force the most redesign work. For businesses that sell insurance as a feature of something else, whether a loan, a hospital admission, a vehicle repair or a checkout, the paper rewrites who may distribute, how a bundle may be presented and how front-line staff may be paid.

According to MediaNama's reading of the paper (30 September 2026), three changes matter most for embedded programmes:

1. Banks and NBFCs registered as distribution entities may not compulsorily bundle insurance with loans, and volume- or reward-linked staff incentives would be prohibited.
2. Hospitals could become distribution entities for health insurance.
3. Non-dealer garages could sell motor insurance as insurer associates.

All three sit inside a simplified intermediary structure with three tiers: insurance distribution entities (IDEs), insurance distribution persons (IDPs) and market infrastructure institutions (MIIs). IDPs are the individual layer (agents and PoSPs), and MIIs are shared market infrastructure such as Bima Sugam, so for most embedded partners the first question is whether to register as an IDE or sell through one. The second is what the current customer journey looks like once the new conduct rules are applied to it.

This post is written for the businesses that embed cover: fintech lenders, NBFCs, hospital chains, auto and mobility platforms, and commerce marketplaces. The borrower-rights side of loan-linked cover is covered in our post on insurance as a loan condition for MSME borrowers; here the focus is product and operating design. For the tier mechanics from a broker's point of view, see our explainer on IDE, IDP and MII appointments.

The proposal does not ban insurance alongside a loan. It bans compulsory bundling by a bank or NBFC registered as a distribution entity, and it sets conditions on any package that remains. As reported by MediaNama, a package is allowed only where:

• the customer gets a demonstrable benefit from taking the two together;
• the customer is shown the rate with insurance and without insurance;
• the customer can choose any insurer, not only the lender's partner;
• the premium is paid separately rather than folded into the loan.

Each condition maps to a specific feature of how many credit-linked programmes run today. Financing the premium into the principal, defaulting a single partner insurer in the journey, and quoting one blended price are common patterns in digital lending. Under the proposal, each of those would need to change.

The "demonstrable benefit" test

The paper, as reported, does not reduce the benefit test to a formula. A lender that wants to keep a package will need to show, product by product, why the combination is better for the borrower than buying each separately. That is a documentation and product-governance task as much as a pricing one. A lender that cannot articulate the benefit for a given product should assume the package will not survive scrutiny and plan an unbundled journey instead.

Separate premium payment

Separate payment is the condition with the largest systems impact. Programmes that deduct premium from the disbursal amount, or add it to the EMI schedule, would need a distinct premium collection flow, with its own receipt, refund path and reconciliation. Lenders that already run insurance as a separate order in their checkout will find this easier than those that built cover into the loan ledger.

The second credit-linked change is about people rather than product. Volume- or reward-linked incentives for staff of banks and NBFCs would be prohibited, per MediaNama's summary. In many branch and field-sales models, insurance attachment has been a target alongside disbursal, with contests, slabs and per-policy rewards to match.

Removing that lever changes attachment economics in two ways. First, attachment rates that were sustained by incentives will fall, and the business case for some partnerships will need to be rebuilt on what customers choose when nothing pushes them. Second, the compliance burden moves to compensation design: HR and sales-operations teams will need to show that variable pay for customer-facing staff is not tied to insurance volume.

For digital lenders the equivalent is less obvious but still present. A journey that defaults a cover toggle to "on", or places the decline option behind extra taps, does the same work as a sales incentive. The paper's customer-choice conditions (rates with and without cover, free choice of insurer) point toward neutral presentation, and product teams should treat dark-pattern review as part of their submission preparation.

Start the incentive review now, not after the final regulation. Variable pay plans for FY27-28 are usually set months ahead, and an incentive scheme that has to be unwound mid-year is harder to explain to sales teams than one that was never launched.

For lenders that also use insurance to protect their own collateral, our earlier piece on borrower insurance and collateral protection in fintech lending sets out where lender-interest cover ends and borrower-elected cover begins. That distinction will matter when deciding which programmes fall inside the bundling conditions.

The proposal that hospitals could register as distribution entities for health insurance opens a channel that has not existed in a formal sense. Hospitals already sit at the centre of health claims through cashless networks and pre-authorisation. Distribution would add a sales relationship to that servicing one.

For hospital chains, the opportunity is reach at the moment of need: uninsured patients at admission, family members of admitted patients, and outpatient and diagnostic customers who buy repeatedly. The difficulty is that the same institution would both sell the policy and later raise bills under it. That creates conflicts that insurers, regulators and patients will look at closely:

• Point-of-care pressure. A patient being admitted is not in a position to compare products calmly. Sales journeys will need cooling-off and disclosure that reflect that.
• Network steering. A hospital that distributes for one insurer may be seen as steering patients toward plans where it is a preferred provider. Multi-insurer distribution reduces this risk.
• Data separation. Clinical data held for treatment should not drive sales targeting without clear consent and purpose limitation.

Hospital groups considering this should look at how their payer integration is already governed. Our post on payer-provider integration and group health governance covers the controls insurers expect from hospitals in the claims relationship, and many of the same controls would carry over to a distribution role.

The paper, as reported, does not settle every operational question here, such as whether a hospital could distribute products from insurers it does not have a cashless arrangement with. These are exactly the points worth raising in a submission.

Motor insurance at the point of vehicle sale has long run through dealers. The proposal that non-dealer garages could sell motor insurance as insurer associates extends point-of-sale distribution to the much larger repair and service network.

Garages see vehicles at renewal-relevant moments: servicing, accident repair and inspections. A garage that can sell or renew a policy at the counter can capture customers whose policy has lapsed or is close to expiry. For insurers, the attraction is access to an older-vehicle segment that dealer channels reach less well.

The design questions are similar to the hospital case. A garage that repairs vehicles under claims and also sells policies has an interest on both sides of the transaction. Insurers appointing garages as associates will need to think about surveyor independence, estimate controls and how renewal sales are presented to customers who came in for repairs.

Auto platforms that already aggregate garages, such as service marketplaces and fleet-maintenance providers, should check where they would sit. A platform routing customers to garages that sell insurance may itself need IDE registration under the three-tier structure, with obligations of its own. The existing dealer model, and how payouts there are being reformed, is covered in our post on MISP and motor dealer payouts.

Commerce, travel, mobility and gig platforms embed cover at checkout or inside an app. Under the proposed structure, they will need to decide whether they register as an IDE themselves or route sales through a registered IDE while acting only as a referral surface. The other two tiers fit few platforms: IDPs are individual salespeople, and MIIs are shared infrastructure rather than a sales channel a single business owns.

Capital is one input to that decision. MediaNama reports IDE capital at Rs 10 lakh plus a deposit of 0.1% of prior-year insurance income. For most platforms the absolute amount is modest, so the decision will turn on conduct obligations, control over the customer journey and how commission or fees are shared, not on capital.

Questions each platform should answer

1. Does the platform choose the insurer and product, or does a registered partner?
2. Who presents price, exclusions and cooling-off terms to the customer?
3. Who handles servicing and claims intimation after the sale?
4. Is cover ever compulsory for completing the main purchase?

The fourth question links back to the credit-linked rules. The paper's bundling conditions, as reported, are framed for banks and NBFCs. Platforms that make cover non-optional for a booking or purchase should not assume they are outside the policy direction, and should check whether their model would be read the same way. Our analysis of embedded insurance API marketplaces describes the technical stacks most platforms use today, which will shape how quickly they can adapt.

The final regulation may differ from the paper, but the direction is clear enough to begin design work. A practical sequence:

1. Map every programme to a tier. List each embedded product and decide whether the business is likely to register as an IDE or act as a referral partner of one.
2. Unbundle price and payment. Build journeys that show the core price with and without cover before the customer commits, and move premium out of loan principal, EMI schedules or blended checkout totals into its own payment and receipt.
3. Open insurer choice. Where only one partner insurer is offered, plan for either multi-insurer options or a clear path for customers to bring their own cover.
4. Rewrite incentive schemes. Remove insurance volume from variable pay and contests for customer-facing staff.
5. Document the benefit case. For any package retained, write down the demonstrable customer benefit and the evidence for it.
6. Separate sales and servicing roles. For hospitals and garages, define controls between the sales function and claims or billing teams.

Feedback on the paper is currently due on 25 October 2026. Whalesbook reported in early October that the Insurance Brokers Association of India has asked for an extension to December. Until IRDAI says otherwise, embedded partners should work to the October date.

Useful submissions are specific and operational. Points worth raising include:

• Definition of demonstrable benefit. Ask for illustrative criteria or examples so that lenders can design packages with some certainty.
• Treatment of existing books. Ask how in-force bundled policies would be handled, including renewals of multi-year credit-linked covers.
• Transition period for systems. Separate premium payment and multi-insurer choice need build time. A phased timeline tied to product type would reduce disruption.
• Hospital and garage conflict controls. Propose concrete safeguards (multi-insurer distribution, separation of billing and sales staff, consent rules for clinical data) rather than simply supporting or opposing the channel.
• Platform classification. Ask for clarity on where a referral surface ends and IDE registration becomes necessary, especially for marketplaces that route customers to garages, clinics or lenders.
• Incentive scope. Ask whether the prohibition covers only direct per-policy rewards or also team targets and broader scorecards that include insurance.

Submissions that pair a concern with a workable alternative tend to carry more weight than objections alone. Businesses that embed insurance have operational data on attachment, cancellations and complaints; using that data to support a position makes a submission harder to set aside. Our coverage of commission disclosure for large commercial policies looks at the commission side of the same paper for readers who need both views.